Tag Archives: Simon Pedder

Cellectar

Cellectar Begins Multiple Melanoma Trial

Cellectar Biosciences, which develops agents to detect, treat and monitor cancers, announced today it has initiated patient dosing in a proof-of-concept trial of I-131-CLR1404 in those with multiple melanoma. “I-131-CLR1404…

Cellectar

Cellectar Applies for Cancer Study

Cellectar Biosciences, which develops agents to detect, treat and monitor cancers, announced today it has applied to the U.S. Food & Drug Administration to begin a¬†clinical study of a highly-selective,…

Photo courtesy of Cellectar

Cellectar Names New CEO

Cellectar Biosciences announced Wednesday that Acting CEO Simon Pedder, PhD., has been promoted to president and CEO. Dr. Pedder began his new role on Tuesday. “I am … appreciative of…